A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.

NCT00077623 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

572

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: epoetin alfa or beta
DRUG: methoxy polyethylene glycol-epoetin beta (Mircera)
DRUG: methoxy polyethylene glycol-epoetin beta (Mircera)

Sponsor

Hoffmann-La Roche